Biotech 2025: Breakthrough Cures, Super Crops, and a Green Tech Revolution
The global biotech market is set to rise from $483 billion in 2024 to $546 billion in 2025. Casgevy, the first CRISPR-based gene therapy for sickle cell disease, will reach patients in 2025. Novo Nordisk and Eli Lilly invested billions to resolve U.S. shortages of GLP-1 drugs. Over 60% of new crop varieties in 2025 use advanced gene-editing, not traditional breeding.